Navigation Links
NxStage Medical Reports First Quarter 2008 Results
Date:5/12/2008

Company to Host Webcast Featuring Synchronized Slides at 5pm Today

LAWRENCE, Mass., May 12 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its financial results for the first quarter ended March 31, 2008.

Revenues for the first quarter of 2008 were $31.0 million, compared to $8.4 million in the first quarter of 2007 and $29.9 million in the fourth quarter of 2007. Revenues in the in-center market, from the Company's Medisystems in-center business, were $16.1 million in the first quarter of 2008, compared to $15.7 million in the fourth quarter of 2007. Revenues in the home dialysis market were $10.5 million for the first quarter of 2008, compared to $5.4 million in the first quarter of 2007 and $9.3 million in the fourth quarter of 2007. Revenues in the critical care market for the first quarter of 2008 were $4.3 million, compared to $2.9 million in the first quarter of 2007 and $4.9 million in the fourth quarter of 2007.

NxStage reported a net loss of $13.9 million, or ($0.38) per share, based on shares outstanding as of March 31, 2008, for the first quarter of 2008 compared with a net loss of $12.0 million, or ($0.41) per share, for the first quarter of 2007. For the first quarter of 2008 the Company had an Adjusted EBITDA loss of $8.3 million, compared to a loss of $10.7 million in the first quarter of 2007 (see the exhibits for a reconciliation of this non-GAAP measure).

Cash, cash equivalents and short term investments as of March 31, 2008 were $16.2 million. In addition, the Company has availability of $20 million under its revolving debt facility.

At the end of the first quarter 2008, NxStage was working with 3
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. NxStage Medical Completes Acquisition of Medisystems
2. NxStage Medical Reports Third Quarter 2007 Results
3. NxStage Medical Establishes $50 Million Credit Facility with a Group of Lenders Led by Merrill Lynch Capital
4. NxStage(R) Medical to Report Fourth Quarter & Full Year 2007 Financial Results on Tuesday, February 12th
5. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
6. NxStage Medical Reports Fourth Quarter and Full Year 2007 Results
7. Emil Paganini, MD, Joins NxStage(R) as Critical Care Medical Advisor
8. Tsongas Visits Lawrence-based Medical Device Maker NxStage Medical, Inc.
9. NxStage Announces Supply Agreement With Kawasumi Laboratories for Blood Tubing Sets
10. MSU engineering team designs innovative medical device
11. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... 3D Global Solutions is plea...gram managing the proposal effort for ReSound who ...Digital Hearing Aid contract. The award includes n...Department of Defense and other federal agencies. ...vember 8, 2009 -- 3D Global Solutions is pleased t...
(Date:11/8/2009)..., "One victory does not mean the battle is won,"... 7 In a vote of 240-194...inski-Smith Amendment to prohibit abortion mandate.... ,, Americans United for Life Action President... this amendment is a victory for the pro-life Amer...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 T...Director, Operation Rescue Insurrecta Nex. ,, ...ry have been fighting to keep child-killing by abo..., Mr. Terry states: "This is a great first step to...t we have a lot of fighting ahead of us. Our rejoi...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 K...h Insurance Plans (AHIP), released the following s..., "Health plans strongly support comprehensive hea...iscussion by proposing a complete overhaul of how ...e proposed guaranteed coverage, elimination of pre...
(Date:11/7/2009)..., HOUSTON, Nov. 7 Calling this a ...tion (AMA), the AMA President J. James Rohack, M.D...sicians from all state and medical specialty socie...y-making meeting, where health system reform will ...com/cgi-bin/prnh/20081209/AMALOGO ) ,, "Over ...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
...IRVINE, Calif., March 4 ISTA Pharmaceuticals,Inc.... fourth quarter 2007,financial results on March 6,...t a conference call, with a simultaneous webcast, ... and Canadian participants may,dial 866-831-6270; ...
...These flat growths are relatively common and tend ... March 4 (HealthDay News) -- While the majority of..., a new study challenges that assumption and point...he Journal of the American Medical Association r...
..., CHARLESTON, S.C. (March 4, 2008) In the curren...m from the Medical University of South Carolinas (... experience with a novel imaging technique that en... Powers, MD, medical director of MUSC Heart and Va...
...HARRISBURG, Pa., March 4 Governor Edward G.,Rende...t public support for,the Governor,s Cover All Penn...n of a tax increase on cigarettes and tobacco prod...mittee that continuing the Mcare abatement will he...
...PHILADELPHIA, March 4 Independence Blue Cross and...ladelphia announced today that,they have reached a...s,unusual in this market and a first in the histor...ital, serving the,special health care needs of chi...
...ALLEGAN, Mich., March 4 Perrigo Company,(Nasdaq: ...ipping 20 mg,Omeprazole delayed released tablets t...same medicine at the same dose as Prilosec OTC(R)....r-the-counter,market in the United States of the D...
Other Medicine News:Health News:Non-Polyp Colon Lesions Hard to Detect 2Health News:Non-Polyp Colon Lesions Hard to Detect 3Health News:Comprehensive diagnosis of heart disease with a single CT scan 2Health News:Governor Rendell's Health Care Reform Cabinet Says Providing Access to Health Care for Pennsylvania's Uninsured is Within Reach 2Health News:Governor Rendell's Health Care Reform Cabinet Says Providing Access to Health Care for Pennsylvania's Uninsured is Within Reach 3Health News:Governor Rendell's Health Care Reform Cabinet Says Providing Access to Health Care for Pennsylvania's Uninsured is Within Reach 4Health News:Independence Blue Cross and The Children's Hospital of Philadelphia Reach Seven-Year Agreement 2Health News:Independence Blue Cross and The Children's Hospital of Philadelphia Reach Seven-Year Agreement 3Health News:Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets 2Health News:Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets 3
(Date:11/6/2009)...PRNewswire/ -- Philips Respironics applauds the ef...ntion (CDC) to raise awareness about an important .... The CDC,s release of the first-ever government s...plessness is a milestone in quantifying the size a...cator, industry leader and sleep therapy manufactu...
(Date:11/6/2009)...e-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) ...cial results for the second quarter ended October ...on Wednesday, November 18, 2009 at 5:00 PM EST. T...ss those results on Thursday, November 19, 2009 at...ter Results Conference Call Instructions ,, T...
(Date:11/6/2009)...ewswire/ -- , - Trial Will Compare NXL103...nt of Multi-Resistant Staphylococcus Aureus (MRSA)...aceutical company focused on the discovery and,dev... the significant global,problem of microbial resis...,antibacterial NXL103 (flopristin/linopristin), ha...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Second Quarter Financial Results 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Americas No 1 Pharmacy Names Great Health as Its Exclusive Health and Wellness Magazine 56168 1Rodgers Introduces SamarionSolution to International Audience 56164 1Rodgers Introduces SamarionSolution to International Audience 56164 2The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 13836 1The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 13836 2The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 13836 3
...SINESS WIRE)--May 29, 2007 - HepaLife Technologies...sed to announce a,scientific presentation of its c... vaccine production at the "Options for the,Contro...23, 2007,in Toronto, Canada., Entitled "High tite...n immortalized chick embryo cell line without the ...
...USINESS WIRE)--May 29, 2007 - Mitopharm Corporatio...f a research paper,where Professor Dr. Robert Ko p...the precursor of (-) Schisandrin B - a novel,disco...research paper entitled "SCHISANDRIN B PROTECTS AG...HANCING MYOCARDIAL,GLUTATHIONE ANTIOXIDANT STATUS"...
Other Medicine Technology:HepaLife Announces Scientific Presentation of PBS-1 Cell Line at,International Influenza Meeting 2HepaLife Announces Scientific Presentation of PBS-1 Cell Line at,International Influenza Meeting 3HepaLife Announces Scientific Presentation of PBS-1 Cell Line at,International Influenza Meeting 4HepaLife Announces Scientific Presentation of PBS-1 Cell Line at,International Influenza Meeting 5Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 2Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 3
Hardy Nasal Bivalve Specula
Triad Facet Screws
Cushing Pituitary Spoons
...terior Spinal Implant system. Material that has a ...al bone. The result is an implant that meets the s... while optimizing the fusion environment through a...mic design with 5 and 10 degrees of lordosis. Mini...
Medicine Products: